Goffredo Angioni

516 total citations
9 papers, 17 citations indexed

About

Goffredo Angioni is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Goffredo Angioni has authored 9 papers receiving a total of 17 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Virology and 3 papers in Emergency Medicine. Recurrent topics in Goffredo Angioni's work include HIV/AIDS drug development and treatment (3 papers), HIV-related health complications and treatments (3 papers) and HIV Research and Treatment (2 papers). Goffredo Angioni is often cited by papers focused on HIV/AIDS drug development and treatment (3 papers), HIV-related health complications and treatments (3 papers) and HIV Research and Treatment (2 papers). Goffredo Angioni collaborates with scholars based in Italy. Goffredo Angioni's co-authors include Giordano Madeddu, Lucia Taramasso, Barbara Menzaghi, Giuseppe Vittorio De Socio, Elena Ricci, Antonio Cascio, Antonio Di Biagio, Nicola Squillace, Benedetto Maurizio Celesia and Paolo Bonfanti and has published in prestigious journals such as Frontiers in Immunology, Viruses and Biomedicines.

In The Last Decade

Goffredo Angioni

5 papers receiving 17 citations

Peers

Goffredo Angioni

ID

VIROL

MB

EM

EPIDE

Pedro Simoes United Kingdom

Laëtitia Moinot France

Geoffrey Chen United States

Anna Csala United Kingdom

M Abwola Uganda

Sonia Calzado Isbert Spain

Sila Ataca United States

Lila Close Spain

Rachele Pincino Italy

Stephen Bondoc United States

Pedro Simoes United Kingdom

Goffredo Angioni

10 ×0.7

ID

7 ×1.0

VIROL

3 ×1.0

MB

4 ×1.3

EM

0 ×0.0

EPIDE

Citations per year, relative to Goffredo Angioni Goffredo Angioni (= 1×) peers Pedro Simoes

Countries citing papers authored by Goffredo Angioni

Since Specialization

Citations

This map shows the geographic impact of Goffredo Angioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goffredo Angioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goffredo Angioni more than expected).

Fields of papers citing papers by Goffredo Angioni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Goffredo Angioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goffredo Angioni. The network helps show where Goffredo Angioni may publish in the future.

Co-authorship network of co-authors of Goffredo Angioni

This figure shows the co-authorship network connecting the top 25 collaborators of Goffredo Angioni. A scholar is included among the top collaborators of Goffredo Angioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Goffredo Angioni. Goffredo Angioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Ricci, Elena, Stefania Piconi, Stefania Cicalini, et al.. (2025). Clinical use of dalbavancin in the Italian SUSANA cohort (SUrveillance of SAfety and outcome of New Antibiotics).. PubMed. 48(1). 35–45.

2.

Vito, Andrea De, G. Conti, Benedetto Maurizio Celesia, et al.. (2025). P100 Real-life use of bictegravir/TAF/emtricitabine in a cohort of people with HIV with more than 50 years old. A160–A161.

3.

Ricci, Elena, Matteo Faltoni, Giordano Madeddu, et al.. (2024). Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infections. Journal of Global Antimicrobial Resistance. 39. 4–4.

4.

Vito, Andrea De, Andrea Marıno, Manuela Ceccarelli, et al.. (2024). Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort. Biomedicines. 12(10). 2311–2311. 1 indexed citations

5.

Vito, Andrea De, Barbara Menzaghi, Andrea Calcagno, et al.. (2024). Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned?. Healthcare. 12(4). 417–417.

6.

Littera, Roberto, Stefania Tranquilli, Aldesia Provenzano, et al.. (2022). A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population. Frontiers in Immunology. 13. 891147–891147. 3 indexed citations

7.

Firinu, Davide, et al.. (2022). Successful Combination of Remdesivir and Convalescent Plasma to Treata Patient with Rituximab-Related B-Cell Deficiency and ProlongedCOVID-19: A Case Report. Anti-Infective Agents. 21(2). 1 indexed citations

8.

Taramasso, Lucia, Giancarlo Orofino, Elena Ricci, et al.. (2022). Reversibility of Central Nervous System Adverse Events in Course of Art. Viruses. 14(5). 1028–1028. 9 indexed citations

9.

Taramasso, Lucia, Elena Ricci, Antonio Cascio, et al.. (2019). Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA). AIDS Research and Therapy. 16(1). 21–21. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact